Concepedia

Arianna De Rosa

AD

Statistics

Publications

13

Citations

347

H-Index

12

Active since

2001

Affiliations

CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)(Current)

University of Naples Federico II

University of Campania "Luigi Vanvitelli"

Federico II University Hospital

Istituti di Ricovero e Cura a Carattere Scientifico

Arianna De Rosa is an author at CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) specializing in neuroscience, life sciences, and molecular neuroscience.

ORCID

Publications per year

2001–2023

13

Publications

13

Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias

Jennifer Stanic, Manuela Mellone, Francesco Napolitano et al. · Neurobiology of Disease · 2017 · 47 citations · Full text

, , +17

Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain

Arianna De Rosa, Andrea Fontana, Tommaso Nuzzo et al. · Schizophrenia · 2022 · 39 citations · Full text

, , +17

RasGRP1 is a causal factor in the development of <scp>l</scp> -DOPA–induced dyskinesia in Parkinson’s disease

Mehdi Eshraghi, Uri Nimrod Ramírez-Jarquín, Neelam Shahani et al. · Science Advances · 2020 · 37 citations · Full text

, , +14

Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients

Anna Maio, Tommaso Nuzzo, Luana Gilio et al. · Neurobiology of Disease · 2023 · 33 citations · Full text

, , +17

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

Valeria Calabrese, Anna Maio, Gioia Marino et al. · Frontiers in Aging Neuroscience · 2020 · 27 citations · Full text

, , +17

1–5 of 13